YOU SEARCHED BY...
SEARCH BY...
Contract Service Directory
Country
- Argentina(1)
- Australia(8)
- Austria(1)
- Belgium(3)
- Canada(60)
- China(20)
- Denmark(2)
- Estonia(2)
- Finland(1)
- France(13)
- Germany(38)
- Greece(2)
- Hong Kong(1)
- Hungary(3)
- India(75)
- Ireland(1)
- Israel(3)
- Italia (6)
- Japan(2)
- Latvia(1)
- Lithuania(1)
- Mexico(2)
- New Zealand(1)
- Peru(1)
- Poland(2)
- Portugal(3)
- Romania(1)
- Singapore(1)
- Slovenia(2)
- South Korea(6)
- Spain(15)
- Sweden(3)
- Switzerland(22)
- Taiwan(3)
- The Czech Republic(1)
- The Netherlands(5)
- Turkey(2)
- Ukraine(1)
- United Kingdom(52)
- United States(675)
- Vietnam(1)
Contract Service Directory
Actylis
Company Headquarters
4 Tri Harbor Court,
Port Washington, NY 11050
United States
Contract Service Directory
- Chemicals and Raw Materials
- Custom Manufacturing
- Custom Media Development
- Custom Sourcing
- Excipients
- Manufacturing, API
- Manufacturing, Biologics
- Manufacturing, Custom
- Manufacturing, Nutraceuticals
- Process Development/Scale-Up Services
- Process R&D
- R&D Services
- Supplier, Excipients
- Supplier, Fine Chemicals
- Supplier, Raw Materials
Content From Actylis
-
Videobite: Contract Pharma Talks with Tony Kelleher of Actylis
Facility Director of Actylis Limerick discusses ensuring quality of biopharma raw materials and success stories adapting manufacturing processes.Videos Released on 03.27.2024
Related Content
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss
Novel AAV capsid Anc80 enables efficient gene transfer.02.01.23
-
Breaking News | Promotions & Moves
Exothera Names Darren Leva as Chief Business Officer
Leva brings 20 years of broad commercial expertise to Exothera from a range of experiences with CDMOs, therapeutics, and software companies.02.01.23
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
New CDMO Vector BioMed Launches Operations
The biomanufacturing company’s mission is to provide access to high-quality lentiviral vectors and address the vector supply bottleneck.02.01.23
-
Breaking News | Drug Development | Facilities | Industry News
Mikart Invests in New Liquids and Suspensions Suite
Enhances liquid oral drug product development and manufacturing capabilities of complex formulations.02.01.23
